{"id":149,"date":"2024-06-18T11:36:16","date_gmt":"2024-06-18T15:36:16","guid":{"rendered":"https:\/\/www.packagingindustrynews.com\/?p=149"},"modified":"2024-06-25T15:28:33","modified_gmt":"2024-06-25T19:28:33","slug":"boston-scientific-weaves-a-1-16b-acquisition","status":"publish","type":"post","link":"https:\/\/www.packagingindustrynews.com\/?p=149","title":{"rendered":"Boston Scientific Weaves a $1.16B Acquisition"},"content":{"rendered":"<p> <br \/>\n<\/p>\n<div data-module=\"content\">\n<p class=\"ContentParagraph ContentParagraph_align_left\" data-testid=\"content-paragraph\"><span class=\"ContentText ContentText_variant_bodyNormal\" data-testid=\"content-text\">Boston Scientific&#8217;s road to transcarotid artery revascularization (TCAR) has been paved by Silk Road Medical \u2013 in the form of a $1.16 billion acquisition.<\/span><\/p>\n<p class=\"ContentParagraph ContentParagraph_align_left\" data-testid=\"content-paragraph\"><span class=\"ContentText ContentText_variant_bodyNormal\" data-testid=\"content-text\">Silk Road Medical has long been considered one of the <\/span><span class=\"ContentText ContentText_variant_bodyNormal\" data-testid=\"content-text\"><a class=\"ContentText-BodyTextChunk ContentText-BodyTextChunk_link\" target=\"_blank\" href=\"https:\/\/www.mddionline.com\/business\/25-most-attractive-medtech-m-a-targets-in-2022\" rel=\"noopener\">25 Most Attractive Medtech M&amp;A Targets<\/a><\/span><span class=\"ContentText ContentText_variant_bodyNormal\" data-testid=\"content-text\"> for its innovative platform of products designed to prevent stroke in patients with carotid artery disease through the TCAR procedure.<\/span><\/p>\n<p class=\"ContentParagraph ContentParagraph_align_left\" data-testid=\"content-paragraph\"><span class=\"ContentText ContentText_variant_bodyNormal\" data-testid=\"content-text\">TCAR combines the surgical principles of neuroprotection with minimally invasive endovascular techniques to treat blockages in the carotid artery at risk for causing a stroke.<\/span><\/p>\n<p class=\"ContentParagraph ContentParagraph_align_left\" data-testid=\"content-paragraph\"><span class=\"ContentText ContentText_variant_bodyNormal\" data-testid=\"content-text\">Marie Thibault, a medtech analyst at BTIG, noted in a report Tuesday that her team views the deal as a tuck-in for Boston Scientific that will help expand its peripheral interventions segment by reaching existing physician call points.<\/span><\/p>\n<p class=\"ContentParagraph ContentParagraph_align_left\" data-testid=\"content-paragraph\"><span class=\"ContentText ContentText_variant_bodyNormal\" data-testid=\"content-text\">&#8220;We think [Boston Scientific] can use its resources to increase TCAR penetration within the U.S., launch new products, and expand into new markets, including Japan and China, while continuing to improve the business&#8217; margins,&#8221; Thibault wrote. &#8220;While there are several companies that may have interest in TCAR, we think the transaction price represents a reasonable valuation for [Silk Medical] given anticipated sales growth rate and EBITDA margin profile.&#8221;<\/span><\/p>\n<p class=\"ContentParagraph ContentParagraph_align_left\" data-testid=\"content-paragraph\"><span class=\"ContentText ContentText_variant_bodyNormal\" data-testid=\"content-text\">Treatment of carotid artery disease includes medication, stents, or surgery to reduce the risk of stroke. The TCAR procedure involves accessing the carotid artery through a small incision in the neck and temporarily reversing blood flow away from the brain to prevent plaque from dislodging and causing a stroke. A stent is then placed at the site of the blockage for long-term plaque stabilization and future stroke prevention.<\/span><\/p>\n<p class=\"ContentParagraph ContentParagraph_align_left\" data-testid=\"content-paragraph\"><span class=\"ContentText ContentText_variant_bodyNormal\" data-testid=\"content-text\">FDA approved the TCAR system in 2015 and the technique is backed by clinical data demonstrating a reduced risk of stroke and other complications associated with traditional open surgery.<\/span><\/p>\n<p class=\"ContentParagraph ContentParagraph_align_left\" data-testid=\"content-paragraph\"><span class=\"ContentText ContentText_variant_bodyNormal\" data-testid=\"content-text\">&#8220;The TCAR platform developed by Silk Road Medical is a notable advancement in the field of vascular medicine, which has revolutionized stroke prevention and the treatment of carotid artery disease,&#8221; said Cat Jennings, president of Boston Scientific&#8217;s vascular and peripheral interventions business.<\/span><\/p>\n<p class=\"ContentParagraph ContentParagraph_align_left\" data-testid=\"content-paragraph\"><span class=\"ContentText ContentText_variant_bodyNormal\" data-testid=\"content-text\">The companies expect to close the acquisition in the second half of 2024, assuming stockholder and applicable regulatory approvals.<\/span><\/p>\n<\/div>\n<p><br \/>\n<br \/><a href=\"https:\/\/www.packagingdigest.com\/medical-packaging\/boston-scientific-weaves-a-1-16b-acquisition\">Source link <\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Boston Scientific&#8217;s road to transcarotid artery revascularization (TCAR) has been paved by Silk Road Medical \u2013 in the form of a $1.16 billion acquisition. Silk Road Medical has long been considered one of the 25 Most Attractive Medtech M&amp;A Targets for its innovative platform of products designed to prevent stroke in patients with carotid artery [&hellip;]<\/p>\n","protected":false},"author":5,"featured_media":150,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_et_pb_use_builder":"","_et_pb_old_content":"","_et_gb_content_width":"","footnotes":""},"categories":[165],"tags":[],"class_list":["post-149","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-packaging-news"],"_links":{"self":[{"href":"https:\/\/www.packagingindustrynews.com\/index.php?rest_route=\/wp\/v2\/posts\/149","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.packagingindustrynews.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.packagingindustrynews.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.packagingindustrynews.com\/index.php?rest_route=\/wp\/v2\/users\/5"}],"replies":[{"embeddable":true,"href":"https:\/\/www.packagingindustrynews.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=149"}],"version-history":[{"count":1,"href":"https:\/\/www.packagingindustrynews.com\/index.php?rest_route=\/wp\/v2\/posts\/149\/revisions"}],"predecessor-version":[{"id":222,"href":"https:\/\/www.packagingindustrynews.com\/index.php?rest_route=\/wp\/v2\/posts\/149\/revisions\/222"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.packagingindustrynews.com\/index.php?rest_route=\/wp\/v2\/media\/150"}],"wp:attachment":[{"href":"https:\/\/www.packagingindustrynews.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=149"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.packagingindustrynews.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=149"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.packagingindustrynews.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=149"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}